Literature DB >> 16370959

Drug-induced glomerulopathies.

Hassan Izzedine1, Vincent Launay-Vacher, Edward Bourry, Isabelle Brocheriou, Svetlana Karie, Gilbert Deray.   

Abstract

Normal renal function depends upon an intact glomerular apparatus. Many drugs and chemicals are capable of damaging the glomerulus, causing its increased permeability to large molecules. Glomerular lesions are usually responsible for proteinuria and the nephrotic syndrome. This also holds true for the drug-induced glomerulopathies, of which membranous glomerulo-nephritis is the most frequent type of lesion encountered. Apart from this, several cases of different glomerular changes such as focal segmental glomerulosclerosis and crescentic glomerulonephritis have also been reported. The drug-induced glomerulopathies are probably immune mediated. This is, for instance, reflected in the fact that patients with drug-induced nephritic syndrome frequently have the HLA-B8 and DR3 antigens. In depth information is provided for the previously mentioned disorders.

Entities:  

Mesh:

Year:  2006        PMID: 16370959     DOI: 10.1517/14740338.5.1.95

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  8 in total

Review 1.  Drug-induced glomerular disease: attention required!

Authors:  Jai Radhakrishnan; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

2.  Lack of effect of DX-619, a novel des-fluoro(6)-quinolone, on glomerular filtration rate measured by serum clearance of cold iohexol.

Authors:  Nenad Sarapa; Prachi Wickremasingha; Nanxiang Ge; Richard Weitzman; Merynda Fuellhart; Cindy Yen; Julia Lloyd-Parks
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

3.  De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection.

Authors:  Jose L Tovar; Maria Buti; Alfonso Segarra; Joaquim Majó; Rafael Esteban
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

Review 4.  Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.

Authors:  An S De Vriese; Sanjeev Sethi; Karl A Nath; Richard J Glassock; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2018-01-10       Impact factor: 10.121

5.  Collapsing glomerulopathy as a complication of interferon therapy for hepatitis C infection.

Authors:  Sriraj Kanungo; Srinath Tamirisa; Rajalakshmi Gopalakrishnan; Luis Salinas-Madrigal; Bahar Bastani
Journal:  Int Urol Nephrol       Date:  2009-06-04       Impact factor: 2.370

Review 6.  Anti-hepatitis C virus drugs and kidney.

Authors:  Paul Carrier; Marie Essig; Marilyne Debette-Gratien; Denis Sautereau; Annick Rousseau; Pierre Marquet; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2016-11-18

7.  Secondary Membranous Nephropathy. A Narrative Review.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-12-03

8.  Evaluation of podocin in urine in horses using qualitative and quantitative methods.

Authors:  Natalia Siwińska; Urszula Pasławska; Remigiusz Bąchor; Barbara Szczepankiewicz; Agnieszka Żak; Paulina Grocholska; Zbigniew Szewczuk
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.